Vikas Goyal

Vikas Goyal is a declared insider at 3 companies; the most frequent names are Spero Therapeutics, Inc., Morphic Holding, Inc. and Pandion Therapeutics, Inc. Over a trading history stretching from 6 November 2017 to 1 April 2021, the count stands at 12 filings.

Every open-market trade on record is a purchase: 4 purchases worth €9.7M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2021: 1 purchase and no sales on the market.

Half of the purchases are above €2.2M and half below. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 1 April 2021: a transaction of €4.5M, in Pandion Therapeutics, Inc. The last purchase on record was published on 8 March 2021, which is 2,055 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.